Author(s):
Zohra Firdous, Pankaj Dhapake, Nitin Padole, Nilakshi Dhoble, Jagdish Baheti
Email(s):
zohrafirdous.143@gmail.com
DOI:
10.52711/2321-5844.2023.00015 
Address:
Zohra Firdous*, Pankaj Dhapake, Nitin Padole, Nilakshi Dhoble, Jagdish Baheti
Department of Pharmaceutics, Kamla Nehru College of Pharmacy, Butibori, Nagpur 441108, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 2,
Year - 2023
ABSTRACT:
Transdermal drug delivery is a validated technology that makes a significant contribution to global pharmaceutical care. Since 1980, the sector has seen impressive growth with several commercial successes. The term transdermal drug delivery refers to the delivery of a drug across the layers of skin with the intention of allowing the drug to be absorbed through the skin in a predetermined and controlled rate manner. Skin is one of the largest organs that act as an efficient barrier for drug delivery. The present study focuses on the different approaches of nano-carrier system that delivers the nano-carrier drug across the skin barrier with the help of transdermal delivery system. Nano-carrier drug delivery systems are one of the biggest challenges to deliver drug into systemic circulation by crossing the skin barrier providing a passive drug delivery strategy that is known to be safer and faster than the conventional method. In this review, we describe the diverse types of nano-carriers approaches that have been synthesized for transdermal delivery system includes liposomes, niosomes, ethosomes, solid lipid nanoparticles (SLN), nanostructured lipid carrier (NLC), polymeric nanoparticles, nanocrystals, nanofibers and nanosuspension/nanoemulsion. Several characterization methods of transdermal delivery system have been proposed to control the behavior of nano-carriers, along with in-vitro and in-vivo and other evaluation parameters. It was concluded that the compatibility of nano-carriers with the skin structure should be considered for transdermal nanocarrier delivery systems, which will be the most preferred route for drug delivery in the future as it offers high patient compliance, controlled dosing, low frequency of dosing, high physico-chemical stability and better dermal bioavailability, etc.
Cite this article:
Zohra Firdous, Pankaj Dhapake, Nitin Padole, Nilakshi Dhoble, Jagdish Baheti. Different Approaches for Transdermal Nano-Carrier Delivery System. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2):94-4. doi: 10.52711/2321-5844.2023.00015
Cite(Electronic):
Zohra Firdous, Pankaj Dhapake, Nitin Padole, Nilakshi Dhoble, Jagdish Baheti. Different Approaches for Transdermal Nano-Carrier Delivery System. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2):94-4. doi: 10.52711/2321-5844.2023.00015 Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2023-14-2-8
REFERENCE:
1. Brunaugh AD, Smyth HD, Williams III RO. Topical and transdermal drug delivery. Essential Pharmaceutics. 2019: 131-47. DOI: 10.1007/978-3-030-31745-4_9
2. Guy RH. Transdermal drug delivery. Drug Delivery. 2010: 399-410. DOI: 10.1007/978-3-642-00477-3_13
3. Babaie S, Del Bakhshayesh AR, Ha JW, Hamishehkar H, Kim KH. Invasome: A novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020; 10(2): 341. DOI: 10.3390/nano10020341
4. Subedi RK, Oh SY, Chun MK, Choi HK. Recent advances in transdermal drug delivery. Archives of Pharmaceutical Research. 2010; 33(3): 339-51. DOI: 10.1007/s12272-010-0301-7
5. Sharma N, Agarwal G, Rana AC, Bhat ZA, Kumar D. A review: transdermal drug delivery system: a tool for novel drug delivery system. International Journal of Drug Development and Research. 2011; 3(3).
6. Desai JL, Pandya T, Patel A. Nanocarriers in Transdermal Drug Delivery. In Nanocarriers: Drug Delivery System. Springer, Singapore. 2021(pp. 383-409). DOI:10.1007/978-981-33-4497-6_16
7. K. Naga Durga, P. Bhuvaneswari, B. Hemalatha, K. Padmalatha. A Review on Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2022; 12(2): 159-6. Doi: 10.52711/ 2231-5713.2022.00027
8. Rastogi V, Yadav P. Transdermal drug delivery system: An overview. Asian Journal of Pharmaceutics (AJP). 2012; 6(3). doi.org/10.22377/ajp.v6i3.51
9. Carmichael AJ. Transdermal drug delivery: some problems solved, others created. Drugs Therapy Perspectives. 1994; 4: 15–16. doi.org/10.2165/00042310-199404010-00007
10. Rakesh K Sindhu, Mansi Chitkara, Gagandeep Kaur, Preeti Jaiswal, Ashutosh Kalra, Inderbir Singh, Pornsak Sriamornsak. Skin Penetration Enhancer’s in Transdermal Drug Delivery Systems. Research J. Pharm. and Tech. 2017; 10(6): 1809-1815. DOI: 10.5958/0974-360X.2017.00319.5
11. N.K. Jain, A.N. Misra, Transdermal Drug Delivery. Controlled and Novel Drug Delivery. 1st edition; 1997: 100-129.
12. Woo WM. Skin Structure and Biology. Imaging Technologies and Transdermal Delivery in Skin Disorders. 2019 Nov 21:1-4.
13. Venus M, Waterman J, McNab I. Basic physiology of the skin. Surgery (Oxford). 2010; 28(10): 469-72. DOI:10.1016/ J.MPSUR.2010.07.011
14. Yadav N, Parveen S, Chakravarty S, Banerjee M. Skin anatomy and morphology. In Skin Aging and Cancer. Springer, Singapore. 2019 (pp. 1-10). DOI: 10.1007/978-981-13-2541-0_1
15. Brown TM, Krishnamurthy K. Histology, Dermis, StatPearls [Internet]; 2022 Jan.
16. Roberto grujicic, Dimitrios M. Papillary Layer of dermis, KEN HUB; 2022 Dec.
17. Durkin N. The Skin: An Introduction to Medical Science. Springer, Dordrecht. 1979 (pp. 257-263. doi.org/10.1007/978-94-011-6171-8
18. Chien YW. Transdermal controlled-release drug administration. Novel drug delivery systems. 1982; 14: 149-217.
19. Jhawat VC, Saini V, Kamboj S, Maggon N. Transdermal drug delivery systems: approaches and advancements in drug absorption through skin. Int J Pharm Sci Rev Res. 2013; 20(1): 47-56.
20. Brown M.B., Martin G.P., Jones S.A., Akomeah F.K., Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects, Journal of Drug Delivery, 13, 2006; 175-187.
21. Lakshmi Usha Ayalasomayajula, M. Kusuma Kumari, Radha Rani Earle. An Insight into delivery of drug through The Skin: Transdermal Drug Delivery system. Research Journal of Topical and Cosmetic Sciences. 2021; 12(1): 4-2. doi: 10.52711/2321-5844.2021.00002
22. Kaur D, Singh R. A novel approach: Transdermal gel. International Journal of Pharmaceutical Research and Review. 2015; 4(10): 41-50.
23. Chinchole P, Savale S, Wadile K. A novel approach on transdermal drug delivery system [TDDS]. World Journal of Pharmacy and Pharmaceutical Sciences. 2016; 5(4): 932-58.
24. Jain S, Patel N, Shah MK, Khatri P, Vora N. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. Journal of Pharmaceutical Sciences. 2017; 106(2): 423-45.
25. Sharma N., Agarwal G., Rana A.C., Bhat Z.A., Kumar D., A Review: Transdermal Drug Delivery System: A Tool for Novel Drug Delivery System, International Journal of Drug Development and Research. 2011; 3(3): 70-84.
26. Arunachalam A., Karthikeyan M., Viney D.K., Pratap. M., Sethuraman S., Ashutoshkumar S., Manidipa S., Transdermal Drug Delivery System: A Review. Current Pharmaceutical Research, 2010; 1(1): 70-81.
27. Wokovich A.M., Prodduturi, Doub W.H., Hussain A.H., Buhse L.F., Transdermal Drug Delivery System (TDDS) Adhesion as a Critical Safety, Efficacy and Quality Attribute. European Journal of Pharmaceutics and Biopharmaceutics, 2006; 64: 1-8.
28. Nikhil Patel, Chetan Patel, Savan Vachhani, ST Prajapati , CN Patel. Recent Advances in Transdermal Drug Delivery System. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2): 113-119.
29. Tyle P., Drug Delivery Device, 3rd Edition, New York and Basal, Marcel Dekker, 2003; 417-449.
30. Yu Yq, Yang X, Wu Xf, Fan Yb. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Frontiers in Bioengineering and Biotechnology. 2021; 9: 646554.
31. Escobar-Chavez JJ, Rodriguez-Cruz IM, Dominguez-Delgado CL. Chemical and physical enhancers for transdermal drug delivery. Pharmacology. 2012; 7: 398-435.
32. Escobar-Chavez JJ, Rodriguez-Cruz IM, Dominguez-Delgado CL, Diaz-Torres R, Revilla-Vazquez AL, Alencaster NC. Nanocarrier systems for transdermal drug delivery. Recent Adv Nov Drug Carr Syst. 2012 Oct 31.
33. Manju R Singh, Mukesh K Nag, Satish Patel, S. J. Daharwal, Deependra Singh. Novel Approaches for Dermal and Transdermal Delivery of Herbal Drugs. Research J. Pharmacognosy and Phytochemistry. 2013; 5(6): 271-279.
34. Maghraby GM, Williams AC, Barry BW. Can drug‐bearing liposomes penetrate intact skin? Journal of Pharmacy and Pharmacology. 2006; 58(4): 415-29.
35. Avinash V, M. S. Umashankar, Damodharan N. Niosomes: A more promising tool to load poorly penetrating drug through skin for the treatment of Acne vulgaris. Research J. Pharm. and Tech. 2020; 13(6): 3035-3040. doi: 10.5958/0974-360X.2020.00536.3
36. Auda SH, Fathalla D, Fetih G, El-Badry M, Shakeel F. Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies. Polymer Bulletin. 2016; 73: 1229-45.
37. Akhtar N, Arkvanshi S, Bhattacharya SS, Verma A, Pathak K. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery. Journal of Liposome Research. 2015; 25(3): 191-201.
38. Kumar N, Dubey A, Mishra A, Tiwari P. Ethosomes: A Novel Approach in Transdermal Drug Delivery System. International Journal of Pharmacy and Life Sciences. 2020; 11(5).
39. Jaiswal PK, Kesharwani S, Kesharwani R, Patel DK. Ethosome: A new technology used as topical and transdermal delivery system. Journal of Drug Delivery and Therapeutics. 2016; 6(3): 7-17.
40. Shraddha Pandey, Shashi Kiran Misra, Nisha Sharma. Ethosomes- A Novelize Vesicular Drug Delivery System. Research J. Pharm. and Tech. 2017; 10(9): 3223-3232. DOI: 10.5958/0974-360X.2017.00572.8
41. Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Delivery. 2005; 12(4): 207-15.
42. Liu M, Wen J, Sharma M. Solid lipid nanoparticles for topical drug delivery: mechanisms, dosage form perspectives, and translational status. Current Pharmaceutical Design. 2020; 26(27): 3203-17.
43. Lopez-Garcia R, Ganem-Rondero A. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): Occlusive Effect and Penetration Enhancement Ability. Journal of Cosmetic, Dermatological Science and Application. 2015; 5(2): 62-72.
44. Jain P, Rahi P, Pandey V, Asati S, Soni V. Nanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effects. Egypt Journal of Basic Application Science. 2017; 4(2): 89-100
45. Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Advanced Pharmaceutical Bulletin. 2020; 10(2): 150
46. Schaffazick S.R., Pohlmann A.R., Dalla-Costa T., Guterres S.l.S. Freeze-drying polymeric colloidal suspensions: Nanocapsules, nanospheres and nanodispersion. A comparative study. European Journal of Pharmaceutics and Biopharmaceutics. 2003; 56: 501–505.
47. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release. 2001; 70: 1–20
48. Zielinska A, Carreiro F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020; 25(16): 3731.
49. Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: A review. Biomaterials Research. 2021; 25: 1-5.
50. Talebi N, Lopes D, Lopes J, Macario-Soares A, Dan AK, Ghanbari R, Kahkesh KH, Peixoto D, Giram PS, Raza F, Veiga F. Natural polymeric nanofibers in transdermal drug delivery. Applied Materials Today. 2023; 30: 101726
51. Kumar L, Verma S, Joshi K, Utreja P, Sharma S. Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities. Future Journal of Pharmaceutical Sciences. 2021; 7(1): 1-7.
52. Huang F, Wei Q, Cai Y. Surface functionalization of polymer nanofibers. Functional Nanofibers and Their Applications. 2012: 92-118.
53. Subramanian S. Preparation, evaluation, and optimization of atorvastatin nanosuspension incorporated transdermal patch. Asian Journal of Pharmaceutics (AJP). 2016; 10(04).
54. Patel M, Shah A, Patel NM, Patel MR, Patel KR. Nanosuspension: A novel approach for drug delivery system. JPSBR. 2011; 1(1): 1-10.
55. Reza KH. Nanoemulsion as a novel transdermal drug delivery system. International Journal of Pharmaceutical Sciences and Research. 2011; 2(8): 1938
56. Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications. Journal of Controlled Release. 2018; 270: 203-25.
57. Wais M, Aqil M, Goswami P, Agnihotri J, Nadeem S. Nanoemulsion-based transdermal drug delivery system for the treatment of tuberculosis. Recent Patents on Anti-infective Drug Discovery. 2017; 12(2): 107-19.
58. Patel V, Sharma OP, Mehta T. Nanocrystal: A novel approach to overcome skin barriers for improved topical drug delivery. Expert Opinion on Drug Delivery. 2018; 15(4): 351-68.
59. Ghasemiyeh P, Mohammadi-Samani S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages. Drug Design, Development and Therapy. 2020: 3271-89.
60. Doge N, Honzke S, Schumacher F, et al. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin-assessment by intradermal microdialysis and extraction from the different skin layers. J Controlled Release. 2016; 242: 25–34.
61. Pyo SM, Hespeler D, Keck CM, Muller RH. Dermal miconazole nitrate nanocrystals–formulation development, increased antifungal efficacy and skin penetration. International Journal of Pharmaceutics. 2017; 531(1): 350–359.
62. Patel V, Sharma OP, Mehta TA. Impact of process parameters on particle size involved in media milling technique used for preparing clotrimazole nanocrystals for the management of cutaneous candidiasis. AAPS Pharmaceutical Science and Technology. 2019; 20(5): 175.
63. Parivesh S, Sumeet D, Abhishek D. Design, evaluation, parameters and marketed products of transdermal patches: A review. Journal of Pharmaceutical Research. 2010; 3(2): 235-40.
64. Hafeez A, Jain U, Singh J, Maurya A, Rana L. Recent advances in transdermal drug delivery system (TDDS): an overview. J Sci Innov Res. 2013; 2(3): 733-44.
65. Bhakti R. Chorghe, Swapnil T. Deshpande, Rohit D. Shah, Swati S. Korabu, Sagar V. Motarwar. Transdermal Drug Delivery System: A Review. Research J. Pharma. Dosage Forms and Tech. 2013; 5(2): 65-69.
66. Mali AD. An updated review on transdermal drug delivery systems. Skin. 2015; 8(9).
67. Anisree GS, Ramasamy C, Wesley JI, Koshy BM. Formulation of transdermal drug delivery system of metoprolol tartrate and its evaluation. Journal of Pharmaceutical Sciences and Research. 2012; 4(10): 1939.
68. Kumar JA, Pullakandam N, Prabu SL, Gopal V. Transdermal drug delivery system: An overview. Int J Pharm Sci Rev Res. 2010; 3: 49-54.
69. Shingade G.M. Review on: recent trend on transdermal drug delivery system. Journal of Drug Delivery and Therapeutics. 2012 Jan 19; 2(1).
70. Naik A, Pechtold LA, Potts RO, Guy RH. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. Journal of Controlled Release. 1995; 37(3): 299-306.
71. Ansari KH, Singhai AK, Saraogi GK. Recent advancement in transdermal drug delivery system. Indian J Pharm Sci. 2011; 3(5): 52-9.
72. Dhiman S, Singh TG, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011; 3(5): 26-34.
73. Keleb E, Sharma RK, Mosa EB, Aljahwi AA. Transdermal drug delivery system-design and evaluation. International Journal of Advances in Pharmaceutical Sciences. 2010; 1(3).
74. Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003; 4: 480-488.
75. Indira Priyadarshini, Bhavana.G. Quality control tests for topical preparations. Dept. Pharm. Analysis. 2016; 4: 27.
76. Patel Chirag J, Tyagi S, Jaimin P. Transdermal Patches: A Review. Consultant. 2012 Nov; 6:0.
77. Durga KN, Bhuvaneswari P, Hemalatha B, Padmalatha K. A Review on Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2022; 12(2): 159-66.
78. Bose P, Jana A, Mandal S, Chandra S. Transdermal Drug Delivery System: Review and Future. Annals of the Romanian Society for Cell Biology. 2021: 3420-36.
79. Bharkatiya M, Nema RK, Bhatnagar M. Designing and characterization of drug free patches for transdermal application. International Journal of Pharmaceutical Sciences and Drug Research. 2010; 2(1): 35-9.
80. Prabhakar D, Sreekanth J, Jayaveera KN. Transdermal drug delivery patches: A review. Journal of Drug Delivery and Therapeutics. 2013; 3(4): 231-21.
81. Niharika Lal, Navneet Verma. Development and Evaluation of Transdermal Patches containing Carvedilol and Effect of Penetration Enhancer on Drug Release. Research J. Pharm. and Tech. 2018; 11(2): 745-752. doi: 10.5958/0974-360X.2018.00140.3
82. Gondaliya D, Pundarikakshudu K. Studies in formulation and pharmacotechnical evaluation of controlled release transdermal delivery system of bupropion. AAPS Pharm Sci. Tech. 2003; 4: 18-26.
83. Panchaguinla, R., Transdermal Delivery of Drug, Indian Journal of Pharmacology. 1997; 29: 140.
84. Mujoriya R, Dhamande KA. Review on transdermal drug delivery system. Res. J. Sci. Tech. 2011; 3(4): 227-231.
85. Sani Singh, Vikas Anand. Evaluation of transdermal drug delivery systems. Sardar Bhagwan Singh P.G. Institute of Bio-Medical Sciences and Research, Uttarakhand. 2017 April 25; 1-42.
86. Jatav Vijay Singh, Saggu Jitendra Singh, Sharma Ashish Kumar, Gilhotra Ritu Mehra, Sharma Anil, Jat Rakesh Kumar. Design, Formulation and in vitro Drug Release from Transdermal Patches containing Nebivolol Hydrochloride as Model Drug. Asian J. Pharm. Res. 2012; 2(4): 136-141.
87. Hanumanaik M, Patil U, Kumar G, Patel SK, Singh I, Jadatkar K. Design, evaluation and recent trends in transdermal drug delivery system: a review. International Journal of Pharmaceutical Sciences and Research. 2012; 3(8): 2393.
88. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/ transdermal delivery. Therapeutic Delivery. 2010; 1(1): 109-131.